AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 AUG 9 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer - A new report in the Medical Journal of Australia describes the potential therapeutic use of metformin for patients with polycystic ovary syndrome (PCOS) who also exhibit aspects of the metabolic syndrome, specifically glucose intolerance, type 2 diabetes, and hyperlipidemia.
Women with PCOS typically have, among other features, ovarian dysfunction and androgen excess, which may be due in part to hyperinsulinemia, explained R.J. Norman and colleagues in Australia. The oral hypoglycemic agent metformin, by addressing hyperinsulinemia, may resolve some other symptoms of PCOS, they proposed.
They pointed out that reducing insulin resistance through lifestyle modifications such as diet and exercise has been shown to improve endocrine and menstrual function in PCOS and thus it comes as no surprise that metformin reduces serum concentrations of insulin and androgens, reduces hirsutism, and to improves ovulation rates.
Although it is not known whether metformin can improve fertility problems experienced by PCOS patients, the drug may aid weight loss to a small extent by acting on visceral adipose tissue ("Metformin and intervention in polycystic ovary ...
Source: HighBeam Research, Metformin May Be Useful For PCOS Patients With Metabolic Syndrome...